The US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 children aged between 2 and 18 years of age in India.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3wnvtkz
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 years
https://ift.tt/eA8V8J
No comments:
Post a Comment